More about

Interstitial Lung Disease

News
October 04, 2022
2 min read
Save

Early detection key in management of lung disease linked to trastuzumab deruxtecan

Early detection key in management of lung disease linked to trastuzumab deruxtecan

Lung disease that patients with cancer experience from the antibody-drug conjugate fam-trastuzumab deruxtecan-nxki can be treated effectively if detected early and managed promptly, according to study results published in ESMO Open.

News
September 29, 2022
2 min read
Save

Short telomeres associated with prevalent ILD in rheumatoid arthritis

Short telomeres associated with prevalent ILD in rheumatoid arthritis

Short telomeres were strongly associated with prevalent interstitial lung disease among patients with rheumatoid arthritis, according to cross-sectional study results published in Respiratory Medicine.

News
September 27, 2022
1 min read
Save

Cough-specific quality of life may predict adverse outcomes in ILD

Cough-specific quality of life may predict adverse outcomes in ILD

Worse cough-specific quality of life appears to be associated with risk for respiratory hospitalization, death and lung transplantation in patients with interstitial lung disease, researchers reported in Chest.

News
September 21, 2022
2 min read
Save

Pirfenidone may slow lung function decline in patients with rheumatoid arthritis-ILD

Pirfenidone may slow lung function decline in patients with rheumatoid arthritis-ILD

In the phase 2 TRAIL1 trial, treatment with pirfenidone slowed the rate of lung function decline in patients with rheumatoid arthritis-associated interstitial lung disease and demonstrated a similar safety profile to that observed in other trials of the drug.

News
September 14, 2022
1 min read
Save

ILD Day: Recent updates in treatment, management of interstitial lung disease

ILD Day: Recent updates in treatment, management of interstitial lung disease

Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases.

News
August 18, 2022
1 min read
Save

Children’s interstitial lung disease tied to high utilization of health care services

Children’s interstitial lung disease tied to high utilization of health care services

Children’s interstitial lung diseases were associated with high utilization of health care services in European countries and subsequent economic burden on health systems, researchers reported in Thorax.

News
August 09, 2022
1 min read
Save

Trajectory of lung function ‘varies considerably’ after ILD diagnosis

Trajectory of lung function ‘varies considerably’ after ILD diagnosis

It is important to consider interstitial lung disease subtypes when applying progressive fibrosing ILD criteria, researchers concluded in an analysis published in European Respiratory Journal.

News
August 01, 2022
1 min read
Save

One-third of patients with rheumatoid arthritis-associated ILD experience acute exacerbation

One-third of patients with rheumatoid arthritis-associated ILD experience acute exacerbation

The incidence of acute exacerbation was nearly one-third in patients with rheumatoid arthritis-associated interstitial lung disease, researchers reported in Chest.

News
July 20, 2022
2 min read
Save

Acute exacerbation most frequent cause of death in patients with rheumatoid arthritis-ILD, IPF

Acute exacerbation most frequent cause of death in patients with rheumatoid arthritis-ILD, IPF

The most frequent cause of death in patients with rheumatoid arthritis-associated interstitial lung disease and also those with idiopathic pulmonary fibrosis is acute exacerbation, researchers reported.

News
June 22, 2022
2 min read
Save

Concomitant medication burden may impact tolerability of antifibrotic therapy in IPF

Concomitant medication burden may impact tolerability of antifibrotic therapy in IPF

Concomitant medication burden is associated with antifibrotic medication intolerance among patients with idiopathic pulmonary fibrosis, according to research published in Annals of the American Thoracic Society.

View more